The new drug, Latuda (lah-TOO-dah, lurasidone), will compete in a crowded market of "atypical" antipsychotics (Zyprexa, Abilify, etc)

The new drug, Latuda (lah-TOO-dah, lurasidone), will compete in a crowded market of "atypical" antipsychotics (Zyprexa, Abilify, etc).

Atypicals are gaining popularity since prescribers are using them for bipolar disorder, depression, and autism...not just psychosis and schizophrenia.

Latuda is now the NINTH oral atypical antipsychotic.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote